| # | Drug | Count |
|---|---|---|
| 0 | METFORMIN | 38 |
| 1 | METFORMIN ER 500 MG | 27 |
| 2 | METFORMIN ER 750 MG | 27 |
| 3 | INSULIN GLARGINE | 23 |
| 4 | NIVOLUMAB | 16 |
| 5 | EMPAGLIFLOZIN | 15 |
| 6 | METFORMIN HYDROCHLORIDE | 12 |
| 7 | DAPAGLIFLOZIN | 11 |
| 8 | METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS | 11 |
| 9 | METFORMIN HYDROCHLORIDE TABLET | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SAXAGLIPTIN | 7 | 0.0048 |
| 1 | NIVOLUMAB AND RELATLIMAB-RMBW | 1 | 0.0019 |
| 2 | VINORELBINE | 9 | 0.0013 |
| 3 | FENOFIBRIC ACID | 1 | 0.0013 |
| 4 | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 4 | 0.0011 |
| 5 | TRIHEXYPHENIDYL HYDROCHLORIDE | 1 | 0.0010 |
| 6 | EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 2 | 0.0007 |
| 7 | EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | 2 | 0.0006 |
| 8 | CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 1 | 0.0006 |
| 9 | NICARDIPINE HYDROCHLORIDE | 1 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lymphocyte Activation Gene-3 Blocker [EPC] | 1 | 0.0019 |
| 1 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 28 | 0.0003 |
| 2 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 22 | 0.0002 |
| 4 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 7 | 0.0002 |
| 5 | Insulin [EPC] | 5 | 0.0001 |
| 6 | CTLA-4-directed Blocking Antibody [EPC] | 5 | 0.0001 |
| 7 | Insulin Analog [EPC] | 38 | 0.0001 |
| 8 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0001 |
| 9 | Antimycobacterial [EPC] | 2 | 0.0001 |